BMRN vs CARR · P/E 40, rev $1.76B vs P/E 43, rev $21.75B
Biomarin Pharmaceutical Inc (BMRN) versus Carrier Global Corp (CARR) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CARR revenue for 2025-12-31 was $21.75B. Net income was $1.48B. Revenue was up 322.4% from 2024-12-31 to 2025-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Not investment advice. Open the BMRN and CARR stock pages for the full models.
Not investment advice.